1. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149–73
2. Semenzato G, Agostini C, Zambello R, et al. Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis: phenotypic and functional evaluations. Ann N Y Acad Sci 1986; 465: 56–73
3. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996; 51: 238–47
4. Costabel U. Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 1992; 9Suppl. 1: 211–4
5. Sulavik SB, Spencer RP, Weed DA, et al. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 1990; 31: 1909–14